1. The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian Insufficiency.
- Author
-
Potorac, Iulia, Laterre, Marie, Malaise, Olivier, Nechifor, Vlad, Fasquelle, Corinne, Colleye, Orphal, Detrembleur, Nancy, Verdin, Hannah, Symoens, Sofie, De Baere, Elfride, Daly, Adrian F., Bours, Vincent, Pétrossians, Patrick, and Pintiaux, Axelle
- Subjects
PREMATURE ovarian failure ,MALE infertility ,GONADAL dysgenesis ,CONGENITAL disorders ,AZOOSPERMIA ,ETIOLOGY of diseases ,DISEASE risk factors - Abstract
Infertility in couples is a common problem, with both female and male factors contributing to similar extents. Severe, congenital disorders affecting fertility are, however, rare. While folliculogenesis and spermatogenesis are generally orchestrated via different mechanisms, some genetic anomalies can impair both female and male gametogenesis. Minichromosome maintenance complex component 9 (MCM9) is involved in DNA repair and mutations of the MCM9 gene have been previously reported in females with premature ovarian insufficiency (POI). MCM9 is also an emerging cancer risk gene. We performed next-generation and Sanger sequencing of fertility and related genes and hormonal and imaging studies in a kindred whose members had POI and disordered spermatogenesis. We identified a homozygous pathogenic MCM9 variant, c.394C>T (p.Arg132*) in three sisters affected by POI due to ovarian dysgenesis and their brother who had normal pubertal development but suffered from non-obstructive azoospermia. Testicular biopsy revealed Sertoli cell-only testicular histopathology. No evidence of early onset cancer was found in the homozygotic family members, but they were all young (<30 years) at the time of the study. In the male patient the homozygous MCM9 variant led to normal pubertal development and hormonal levels but caused a Sertoli-cell-only syndrome with non-obstructive azoospermia. In the homozygous females studied, the clinical, hormonal, and gonadal phenotypes revealed ovarian dysgenesis consistent with previous reports. Active screening for potential colorectal and other cancer risks in the homozygotic MCM9 subjects has been instigated. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF